{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T07:45:39Z","timestamp":1717055139235},"reference-count":29,"publisher":"Baishideng Publishing Group Inc.","issue":"24","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJG"],"published-print":{"date-parts":[[2006]]},"DOI":"10.3748\/wjg.v12.i24.3891","type":"journal-article","created":{"date-parts":[[2016,3,16]],"date-time":"2016-03-16T07:11:27Z","timestamp":1458112287000},"page":"3891","source":"Crossref","is-referenced-by-count":21,"title":["Value of carcinoembryonic antigen and cytokeratins for the detection of recurrent disease following curative resection of colorectal cancer"],"prefix":"10.3748","volume":"12","author":[{"given":"Lu\u00eds C","family":"Fernandes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-115-8-623"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.121.3.439"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-71967-7_4"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/BF02237104"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19891201)64:11<2354::AID-CNCR2820641127>3.0.CO;2-#"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/BF02234298"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/BF02054978"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Fuszek P, Lakatos P, Tabak A, Papp J, Nagy Z, Takacs I, Horvath HC, Lakatos PL, Speer G. Relationship between serum calcium and CA 19-9 levels in colorectal cancer. World J Gastroenterol 2004;10:1890-1892.","DOI":"10.3748\/wjg.v10.i13.1890"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Kim SB, Fernandes LC, Saad SS, Matos D. Assessment of the value of preoperative serum levels of CA 242 and CEA in the staging and postoperative survival of colorectal adenocarcinoma patients. Int J Biol Markers 2003;18:182-187.","DOI":"10.1177\/172460080301800305"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S0748-7983(95)92516-3"},{"key":"ref11","unstructured":"Björklund B, Björklund V. Specificity and basis of the tissue polypeptide antigen. Cancer Detect Prev 1983;6:41-50."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1998.688"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1023\/A:1018890126260"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1996.458"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Correale M, Arnberg H, Blockx P, Bombardieri E, Castelli M, Encabo G, Gion M, Klapdor R, Martin M, Nilsson S. Clinical profile of a new monoclonal antibody-based immunoassay for tissue polypeptide antigen. Int J Biol Markers 1994;9:231-238.","DOI":"10.1177\/172460089400900405"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9098(199608)62:4<239::AID-JSO2>3.0.CO;2-7"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/pros.2990060308"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19880101)61:1>76::AID-CNCR2820610113>3.0.CO;2-G"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19900815)66:4>722::AID-CNCR2820660421>3.0.CO;2-J"},{"key":"ref20","unstructured":"Tizzani A, Casetta G, Cavallini A, Piana P, Piantino P. [Blood and urine determinations of tissue polypeptide antigen in patients with bladder carcinoma]. Minerva Urol Nefrol 1990;42:69-71."},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/0277-5379(90)90081-4"},{"key":"ref22","unstructured":"Fletcher RH, Fletcher SW, Wagner EW. Epidemiologia Clínica Porto Alegre: Artes Médicas; 1989;."},{"key":"ref23","unstructured":"Neter J, Kutner MH, Nachtsheim CJ, Wasserman W. Applied Linear Statistical Models. 4th ed Chicago: Irwin; 1996;."},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1993.03510080047030"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Bast RC Jr, Ravdin P, Hayes DF, Bates S, Fritsche H Jr, Jessup JM, Kemeny N, Locker GY, Mennel RG, Somerfield MR. 2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 2001;19:1865-1878.","DOI":"10.1200\/JCO.2001.19.6.1865"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19850315)55:6<1284::AID-CNCR2820550622>3.0.CO;2-B"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/BF02054122"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1007\/s10434-000-0032-y"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Fernandes LC, Kim SB, Matos D. Cytokeratins and carcinoembryonic antigen in diagnosis, staging and prognosis of colorectal adenocarcinoma. World J Gastroenterol 2005;11:645-648.","DOI":"10.3748\/wjg.v11.i5.645"}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T15:45:54Z","timestamp":1567698354000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v12\/i24\/3891.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006]]},"references-count":29,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.3748\/wjg.v12.i24.3891","relation":{},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2006]]}}}